stella
beta
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation — Stella
Recruiting
Back to Cerebrovascular Event trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong
View full record on ClinicalTrials.gov